ReviewDermatology online journal2026
Surgical approaches in the management of hidradenitis suppurativa: Techniques, risks, and clinical outcomes.
Review in Dermatology online journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hidradenitis suppurativa (HS) is a chronic, progressive, inflammatory dermatologic condition that affects intertriginous areas with high concentrations of apocrine glands. Initial management is medical; however, surgical excision and wound reconstruction are indicated for severe or refractory disease. This study evaluated current surgical techniques for HS and analyzed their associated risks and reported outcomes. Methods: A review of the literature was conducted to assess surgical approaches, including incision and drainage, deroofing, local excision, wide excision, cryoinsufflation, and laser therapies. Reported complication and recurrence rates were analyzed. Results: Wide excision is favored over less extensive techniques for Hurley stage II and III HS, with lower recurrence and complication rates. The estimated overall complication rate for surgical treatment is 11.1% (95% confidence interval [CI], 6.4%-16.9%), and the estimated overall recurrence rate is 16.2% (95% CI, 9.1%-24.9%). Conclusion: These findings support a more aggressive surgical approach when minimizing recurrence is a primary goal. Procedure selection should be individualized based on patient lifestyle, comorbidities, disease location, and long-term efficacy. Further rigorous research into emerging multidisciplinary therapies and surgical innovations is needed to establish an improved standard of care for HS.
Indexed as
Identifiers
42522481What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.